Raben David
CIK 0002034679
Chief Medical Officer
Filings
7
Latest Apr 28, 2026
Issuers covered
1
Showing
7 of 7
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 63% | +0.1% | +6.3% | +23.7% | -21.3% |
| 90 days | 6 | 67% | +2.7% | +8.6% | +13.1% | -19.5% |
| 180 days | 4 | 0% | -17.8% | -17.8% | -16.4% | -19.1% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Raben David has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 7 | Apr 28, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|